Growth Metrics

Rigel Pharmaceuticals (RIGL) EBIT Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 32.96%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -29.67%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -50.81%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 13.47%
7 Evaxion A 62.56 Bn 62.54 Bn - 16.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -12.10%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 55.96%
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn 43.16%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 43.16%
Dec 31, 2025 123.37%
Sep 30, 2025 52.47%
Jun 30, 2025 88.64%
Mar 31, 2025 35.47%
Dec 31, 2024 40.57%
Sep 30, 2024 39.43%
Jun 30, 2024 26.71%
Mar 31, 2024 -29.40%
Dec 31, 2023 28.15%
Sep 30, 2023 31.32%
Jun 30, 2023 32.85%
Mar 31, 2023 -37.60%
Dec 31, 2022 28.46%
Sep 30, 2022 -15.20%
Jun 30, 2022 15.30%
Mar 31, 2022 -12.63%
Dec 31, 2021 -118.69%
Sep 30, 2021 6.71%
Jun 30, 2021 20.65%
Mar 31, 2021 54.50%
Dec 31, 2020 10.45%
Sep 30, 2020 8.27%
Jun 30, 2020 3.48%
Mar 31, 2020 48.85%
Dec 31, 2019 -3.17%
Sep 30, 2019 19.11%
Jun 30, 2019 -16.07%
Mar 31, 2019 -1.52%
Dec 31, 2018 30.03%
Sep 30, 2018 -53.17%
Jun 30, 2018 -23.17%
Mar 31, 2018 -10.68%
Dec 31, 2017 -5.43%
Sep 30, 2017 5.32%
Jun 30, 2017 8.75%
Mar 31, 2017 10.21%
Dec 31, 2016 2.33%
Sep 30, 2016 1.69%
Jun 30, 2016 15.83%
Mar 31, 2016 11.92%
Dec 31, 2015 20.76%
Sep 30, 2015 35.75%
Jun 30, 2015 17.50%
Mar 31, 2015 7.85%
Dec 31, 2014 4.78%
Sep 30, 2014 -5.26%
Jun 30, 2014 -5.70%
Mar 31, 2014 -2.38%
Dec 31, 2013 4.85%
Sep 30, 2013 -35.27%
Jun 30, 2013 -41.75%